Equivalence of Gyn GEC-ESTRO guidelines for image guided cervical brachytherapy with EUD-based dose prescription

Radiat Oncol. 2013 Nov 13:8:266. doi: 10.1186/1748-717X-8-266.

Abstract

Background: To establish a generalized equivalent uniform dose (gEUD) -based prescription method for Image Guided Brachytherapy (IGBT) that reproduces the Gyn GEC-ESTRO WG (GGE) prescription for cervix carcinoma patients on CT images with limited soft tissue resolution.

Methods: The equivalence of two IGBT planning approaches was investigated in 20 patients who received external beam radiotherapy (EBT) and 5 concomitant high dose rate IGBT treatments. The GGE planning strategy based on dose to the most exposed 2 cm3 (D2cc) was used to derive criteria for the gEUD-based planning of the bladder and rectum. The safety of gEUD constraints in terms of GGE criteria was tested by maximizing dose to the gEUD constraints for individual fractions.

Results: The gEUD constraints of 3.55 Gy for the rectum and 5.19 Gy for the bladder were derived. Rectum and bladder gEUD-maximized plans resulted in D2cc averages very similar to the initial GGE criteria. Average D2ccs and EUDs from the full treatment course were comparable for the two techniques within both sets of normal tissue constraints. The same was found for the tumor doses.

Conclusions: The derived gEUD criteria for normal organs result in GGE-equivalent IGBT treatment plans. The gEUD-based planning considers the entire dose distribution of organs in contrast to a single dose-volume-histogram point.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brachytherapy / methods*
  • Dose Fractionation, Radiation
  • Europe
  • Female
  • Humans
  • Models, Theoretical
  • Practice Guidelines as Topic*
  • Radiation Dosage*
  • Radiometry / methods
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted / methods*
  • Rectum / radiation effects
  • Societies, Medical
  • Tomography, X-Ray Computed
  • Urinary Bladder / radiation effects
  • Uterine Cervical Neoplasms / radiotherapy*